C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
SHWZ Equity

Schwazze

OTCMKTS · SHWZ

$0.00
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
46/100 composite
Fundamentals56
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Schwazze earns a Neutral rating with a 46.3 composite score and low 2/5 conviction. Fundamentals provide the strongest pillar at 56.0, supported by the 64.8 gross-margin subscore, 72.0 operating-margin subscore, and 90.0 cash-runway subscore. Regulatory contributes 49.0, reflecting a balanced jurisdiction posture and an 80.0 enforcement subscore, partly offset by a weak 25.0 filing-cadence result. Market contributes 40.0 because institutional pricing feeds provide no current quote, limiting confirmation from trading performance and valuation signals. Editorial ranks last at 30.0, with no newsroom or briefing activity in CIN newsroom coverage. The resulting profile supports neither a premium rating nor an outright bearish stance.

Licensed fundamentals data show year-over-year revenue growth of approximately 2%, indicating limited top-line momentum. Gross margin approaches 38.9%, providing the clearest operating support within the fundamentals pillar, while the operating margin remains negative at roughly 6.4%. EBITDA stands near $11.2 million, but net income is a loss approaching $59.7 million. That divergence leaves the financial condition stretched; positive EBITDA does not erase bottom-line pressure or establish durable liquidity. Primary regulatory filings show no available latest filing date, while the prior 90-day and 180-day windows contain no recorded regulatory events. No enforcement hits support the stronger enforcement subscore, although the absence of a current filing timestamp constrains visibility and keeps regulatory performance below fundamentals.

The principal forward catalyst rests on fundamentals, where margin conversion can lift the composite more effectively than currently absent market or editorial signals. Gross margin already supplies the strongest reported operating base, and positive EBITDA demonstrates some underlying earnings capacity. A sustained move from modest revenue expansion and negative operating margin toward stronger operating profitability would validate the favorable fundamentals subscores while reducing the tension created by the large net loss. Better filing cadence could improve transparency, but it remains secondary to earnings conversion. The single most important signal to watch is whether gross-margin support translates into a positive operating margin in the next primary regulatory filings.

Scored: 2026-09-23Valid through: 2026-11-07Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
IR / PR agency
Elevate IR
IR email
ir@schwazze.com
IR page
Investor relations
Corporate DetailsCompany profile
CEO
Forrest Hoffmaster
SEC CIK
0001622879
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$0.0M
Enterprise value
$185.8M
EV / EBITDA
13.64
Revenue (TTM)
$174.9M
Gross profit (TTM)
$68.0M
EBITDA
$11.2M
Operating margin
-6.3%
Profit margin
-34.1%
Rev growth YoY
2.0%
Return on equity
-50.0%
Return on assets
-1.9%
EPS (TTM)
$-0.94
Wall St. target price
$1.44
Shares outstanding
80.2M
Institutional ownership
0.5%
Beta
76.15
Full-time employees
729
GICS sector
Healthcare
GICS industry
Pharmaceutical Retailers
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Schwazze (SHWZ)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Schwazze (SHWZ), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for SHWZ are maintained by Cannabis Investor News and refreshed throughout the trading day.